New stent shows promise for Hard-to-Treat leg artery disease

NCT ID NCT03349996

Completed Disease control Sponsor: ID3 Medical Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study tested the LifeStream stent graft in 70 people with severe blockages in the iliac arteries (the main arteries in the pelvis). The device is a mesh tube that props open the artery and lines it to keep it clear. Researchers measured how well the artery stayed open after one year and checked for serious side effects. The goal is to see if this device can safely treat complex blockages that are hard to manage with standard stents.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: LifeStream Peripheral Stent Graft System (a mesh tube used to open blocked arteries)
What this could lead to: If successful, this stent graft could offer a durable, minimally invasive option for treating severe blockages in the iliac arteries, potentially reducing the need for repeat procedures.
What could go wrong: This is a small, completed trial with no control group, so results may not apply to all patients. Risks include re-blockage, serious adverse events, or the device not performing better than existing treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERIAL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

peripheral arterial disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PERIPHERAL ARTERIAL DISEASE

Contacts and locations

Locations

A.Z. Sint-Blasius

Dendermonde, 9200, Belgium
Az Groeninge

Kortrijk, 8500, Belgium
Imelda Hospital

Bonheiden, 2820, Belgium
O.L.V. Hospital

Aalst, 9300, Belgium
R.Z. Heilig Hart

Tienen, 3300, Belgium
Z.N.A.

Antwerp, 2060, Belgium
Z.O.L.

Genk, 3600, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.